Contact Us
Next-Generation Sequencing (NGS) In Precision Medicine Global Market Report 2025
Global Next-Generation Sequencing (NGS) In Precision Medicine Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Next-Generation Sequencing (NGS) In Precision Medicine Global Market Report 2025

By Product And Service (Sequencing Instruments, Consumables And Reagents, Library Preparation Kits, Bioinformatics Software, Next-Generation Sequencing (NGS) Services); By Technology (Whole Genome Sequencing (WGS), Whole Exome Sequencing (Wes), Targeted Sequencing, Ribonucleic Acid (RNA) Sequencing, Single-Cell Sequencing); By Application (Oncology, Infectious Disease, Rare And Inherited Disorders, Prenatal And Reproductive Health, Pharmacogenomics); By End Use (Hospitals And Clinics, Academic And Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations (CROs)); Subsegments:; By Sequencing Instruments (Benchtop Sequencers, High Throughput Sequencers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

• Next-Generation Sequencing (NGS) In Precision Medicine market size has reached to $5.47 billion in 2024

• Expected to grow to $12.03 billion in 2029 at a compound annual growth rate (CAGR) of 17%

• Growth Driver: Rising Incidence Of Genetic Disorders Driving The Growth Of The Market Due To Enhanced Detection And Diagnosis Capabilities

• Market Trend: Multimodal DNA And RNA Library Kit Advances Efficiency In Multiomic NGS For Precision Medicine

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next-Generation Sequencing (NGS) In Precision Medicine Market?

Next-generation sequencing (NGS) in precision medicine refers to an advanced genomic technology that enables the rapid and comprehensive decoding of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequences at an unprecedented scale and speed, offering far deeper insights than traditional sequencing methods. It serves as a core component of precision medicine by providing a detailed view of individual genetic variation and molecular profiles, which form the basis for highly informed medical understanding and decision-making.

The main types of products and services in next-generation sequencing (NGS) in precision medicine are sequencing instruments, consumables and reagents, library preparation kits, bioinformatics software, and next-generation sequencing (NGS) services. Sequencing instruments are specialized machines used to read and decode the DNA or RNA sequence of biological samples. It includes various technologies, such as whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, ribonucleic acid (RNA) sequencing, and single-cell sequencing, and finds applications in oncology, infectious disease, rare and inherited disorders, prenatal and reproductive health, and pharmacogenomics. Key end users include hospitals and clinics, academic and research institutions, biopharmaceutical companies, diagnostic laboratories, and contract research organizations (CROs).

Next-Generation Sequencing (NGS) In Precision Medicine Market Size and growth rate 2025 to 2029: Graph

What Is The Next-Generation Sequencing (NGS) In Precision Medicine Market Size 2025 And Growth Rate?

The next-generation sequencing (NGS) in precision medicine market size has grown rapidly in recent years. It will grow from $5.47 billion in 2024 to $6.42 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to increased government funding for genomics research, rising prevalence of genetic diseases, growth of national biobank initiatives, increased demand for targeted drugs and biomarker discovery, and emergence of multi-omics platforms.

What Is The Next-Generation Sequencing (NGS) In Precision Medicine Market Growth Forecast?

The next-generation sequencing (NGS) in precision medicine market size is expected to see rapid growth in the next few years. It will grow to $12.03 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to growing demand for personalized medicine, expanding applications beyond human genomics, rising prevalence of cancer, expansion to non-communicable disease detection, and growing awareness and accessibility of genetic testing. Major trends in the forecast period include integration with next-generation sequencing, artificial intelligence-enabled bioinformatics pipelines, integration of advanced imaging for enhanced diagnostics and treatment, advancements in sequencing chemistry, and development of cloud-based bioinformatics.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How the Next-Generation Sequencing (NGS) In Precision Medicine Market Segmented?

1) By Product And Service: Sequencing Instruments, Consumables And Reagents, Library Preparation Kits, Bioinformatics Software, Next-Generation Sequencing (NGS) Services

2) By Technology: Whole Genome Sequencing (WGS), Whole Exome Sequencing (Wes), Targeted Sequencing, Ribonucleic Acid (RNA) Sequencing, Single-Cell Sequencing

3) By Application: Oncology, Infectious Disease, Rare And Inherited Disorders, Prenatal And Reproductive Health, Pharmacogenomics

4) By End Use: Hospitals And Clinics, Academic And Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations (CROs)

Subsegments:

1) By Sequencing Instruments: Benchtop Sequencers, High Throughput Sequencers, Portable Sequencers

2) By Consumables And Reagents: Sequencing Reagents, Sequencing Chips, Flow Cells, Sample Preparation Reagents

3) By Library Preparation Kits: Deoxyribonucleic Acid (DNA) Library Preparation Kits, Ribonucleic Acid (RNA) Library Preparation Kits, Whole Genome Amplification Kits, Target Enrichment Kits

4) By Bioinformatics Software: Data Analysis Software, Data Management Software, Sequence Alignment Software, Variant Calling Software

5) By Next-Generation Sequencing Services: Whole Genome Sequencing Services, Whole Exome Sequencing Services, Targeted Sequencing Services, Ribonucleic Acid (RNA) Sequencing Services, Epigenomic Sequencing Services

What Is Driving The Next-Generation Sequencing (NGS) In Precision Medicine Market? Rising Incidence Of Genetic Disorders Driving The Growth Of The Market Due To Enhanced Detection And Diagnosis Capabilities

The rising incidence of genetic disorders is expected to propel the growth of the next-generation sequencing (NGS) in precision medicine market going forward. Genetic disorders refer to diseases or conditions caused by abnormalities in a person’s DNA, which can be inherited or occur due to mutations. The incidence of genetic disorders is rising as advances in diagnostic technologies, such as genetic screening and next-generation sequencing, are allowing doctors to identify cases that previously went undetected, leading to a higher reported prevalence. Next-generation sequencing in precision medicine helps detect genetic mutations, enabling accurate diagnosis, personalized treatment, and early intervention for genetic disorders. For instance, in May 2024, according to the National Health Service, a UK-based government department, in England, approximately 17,000 people live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. Therefore, the rising incidence of genetic disorders is driving the growth of the next-generation sequencing (NGS) in precision medicine industry.

Who Are The Major Players In The Global Next-Generation Sequencing (NGS) In Precision Medicine Market?

Major companies operating in the next-generation sequencing (NGS) in precision medicine market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Natera Inc., Tempus Labs Inc., 10x Genomics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Fulgent Genetics Inc., Twist Bioscience Corporation, Pacific Biosciences of California Inc., Macrogen Inc., Ultima Genomics Inc., Personalis Inc., Element Biosciences Inc., Genomenon Inc., Strand Life Sciences Pvt. Ltd., and Singular Genomics Systems Inc.

What Are The Key Trends Of The Global Next-Generation Sequencing (NGS) In Precision Medicine Market? Multimodal DNA And RNA Library Kit Advances Efficiency In Multiomic NGS For Precision Medicine

Major companies operating in the next-generation sequencing (NGS) in precision medicine market are focusing on developing innovative solutions, such as multimodal DNA and RNA library kits, to enhance the efficiency and accuracy of genomic analyses. A multimodal DNA and RNA library kit is a laboratory kit that allows simultaneous preparation of sequencing libraries from both DNA and RNA in a single workflow, enabling comprehensive analysis of a sample’s genome and transcriptome. For instance, in May 2024, Qiagen N.V., a Germany-based provider of sample and assay technologies for molecular diagnostics, launched the QIAseq Multimodal DNA and RNA Library Kit, a next-generation sequencing solution that facilitates multiomic studies and advances precision medicine by enabling streamlined DNA and RNA library preparation from a single sample. This kit supports whole genome and whole transcriptome sequencing and downstream target enrichment, facilitating multiomic studies by combining optimized chemistry for DNA and RNA simultaneously. It reduces the need for large sample amounts and labor-intensive procedures found in traditional separate DNA and RNA workflows. By enhancing efficiency in multiomic research, this kit advances precision medicine through better biomarker discovery and disease understanding, particularly in cancer research.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Next-Generation Sequencing (NGS) In Precision Medicine Market? QIAGEN NV Strengthens Forensic Genomics Portfolio With Verogen Inc. Acquisition

In June 2025, Qiagen N.V., a Germany-based provider of sample and assay technologies that offers comprehensive NGS solutions that are central to precision medicine, partnered with Incyte Corporation to develop a companion diagnostic panel for patients with myeloproliferative neoplasms. This collaboration aims to develop a multimodal next-generation sequencing (NGS) companion diagnostic panel to accurately identify mutant CALR and other gene alterations in myeloproliferative neoplasms (MPNs) to guide patient selection and support Incyte’s targeted therapies, ultimately improving treatment outcomes globally. Incyte Corporation is a US-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines.

What Is The Regional Outlook For The Global Next-Generation Sequencing (NGS) In Precision Medicine Market?

North America was the largest region in the next-generation sequencing (NGS) in precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Next-Generation Sequencing (NGS) In Precision Medicine Market?

The next-generation sequencing (NGS) in precision medicine market consists of revenues earned by entities by providing services such as whole genome sequencing, metagenomic sequencing, hereditary cancer screening, pharmacogenomics testing, and rare disease diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation sequencing (NGS) in precision medicine market also includes sales of sequencing instruments, reagents and consumables, bioinformatics software, data analysis tools, and sequencing panels and assays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Next-Generation Sequencing (NGS) In Precision Medicine Industry?

The next-generation sequencing (ngs) in precision medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing (ngs) in precision medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Table Of Contents

1. Executive Summary

2. Next-Generation Sequencing (NGS) In Precision Medicine Market Characteristics

3. Next-Generation Sequencing (NGS) In Precision Medicine Market Trends And Strategies

4. Next-Generation Sequencing (NGS) In Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Next-Generation Sequencing (NGS) In Precision Medicine Growth Analysis And Strategic Analysis Framework

5.1. Global Next-Generation Sequencing (NGS) In Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Next-Generation Sequencing (NGS) In Precision Medicine Market Growth Rate Analysis

5.4. Global Next-Generation Sequencing (NGS) In Precision Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Next-Generation Sequencing (NGS) In Precision Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Next-Generation Sequencing (NGS) In Precision Medicine Total Addressable Market (TAM)

6. Next-Generation Sequencing (NGS) In Precision Medicine Market Segmentation

6.1. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sequencing Instruments

Consumables And Reagents

Library Preparation Kits

Bioinformatics Software

Next-Generation Sequencing (NGS) Services

6.2. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Genome Sequencing (WGS)

Whole Exome Sequencing (Wes)

Targeted Sequencing

Ribonucleic Acid (RNA) Sequencing

Single-Cell Sequencing

6.3. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Infectious Disease

Rare And Inherited Disorders

Prenatal And Reproductive Health

Pharmacogenomics

6.4. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Academic And Research Institutions

Biopharmaceutical Companies

Diagnostic Laboratories

Contract Research Organizations (CROs)

6.5. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Sequencing Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Benchtop Sequencers

High Throughput Sequencers

Portable Sequencers

6.6. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Consumables And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sequencing Reagents

Sequencing Chips

Flow Cells

Sample Preparation Reagents

6.7. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Library Preparation Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Deoxyribonucleic Acid (DNA) Library Preparation Kits

Ribonucleic Acid (RNA) Library Preparation Kits

Whole Genome Amplification Kits

Target Enrichment Kits

6.8. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Bioinformatics Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Data Analysis Software

Data Management Software

Sequence Alignment Software

Variant Calling Software

6.9. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Next-Generation Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Genome Sequencing Services

Whole Exome Sequencing Services

Targeted Sequencing Services

Ribonucleic Acid (RNA) Sequencing Services

Epigenomic Sequencing Services

7. Next-Generation Sequencing (NGS) In Precision Medicine Market Regional And Country Analysis

7.1. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market

8.1. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next-Generation Sequencing (NGS) In Precision Medicine Market

9.1. China Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

9.2. China Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next-Generation Sequencing (NGS) In Precision Medicine Market

10.1. India Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market

11.1. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

11.2. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next-Generation Sequencing (NGS) In Precision Medicine Market

12.1. Australia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next-Generation Sequencing (NGS) In Precision Medicine Market

13.1. Indonesia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market

14.1. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

14.2. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market

15.1. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

15.2. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next-Generation Sequencing (NGS) In Precision Medicine Market

16.1. UK Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next-Generation Sequencing (NGS) In Precision Medicine Market

17.1. Germany Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next-Generation Sequencing (NGS) In Precision Medicine Market

18.1. France Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next-Generation Sequencing (NGS) In Precision Medicine Market

19.1. Italy Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next-Generation Sequencing (NGS) In Precision Medicine Market

20.1. Spain Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market

21.1. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

21.2. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next-Generation Sequencing (NGS) In Precision Medicine Market

22.1. Russia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next-Generation Sequencing (NGS) In Precision Medicine Market

23.1. North America Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

23.2. North America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next-Generation Sequencing (NGS) In Precision Medicine Market

24.1. USA Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

24.2. USA Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market

25.1. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

25.2. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next-Generation Sequencing (NGS) In Precision Medicine Market

26.1. South America Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

26.2. South America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next-Generation Sequencing (NGS) In Precision Medicine Market

27.1. Brazil Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market

28.1. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

28.2. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market

29.1. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market Overview

29.2. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next-Generation Sequencing (NGS) In Precision Medicine Market Competitive Landscape And Company Profiles

30.1. Next-Generation Sequencing (NGS) In Precision Medicine Market Competitive Landscape

30.2. Next-Generation Sequencing (NGS) In Precision Medicine Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Next-Generation Sequencing (NGS) In Precision Medicine Market Other Major And Innovative Companies

31.1. Exact Sciences Corporation

31.2. QIAGEN N.V.

31.3. Natera Inc.

31.4. Tempus Labs Inc.

31.5. 10x Genomics Inc.

31.6. BGI Genomics Co. Ltd.

31.7. Guardant Health Inc.

31.8. Caris Life Sciences Inc.

31.9. Fulgent Genetics Inc.

31.10. Twist Bioscience Corporation

31.11. Pacific Biosciences of California Inc.

31.12. Macrogen Inc.

31.13. Ultima Genomics Inc.

31.14. Personalis Inc.

31.15. Element Biosciences Inc.

32. Global Next-Generation Sequencing (NGS) In Precision Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next-Generation Sequencing (NGS) In Precision Medicine Market

34. Recent Developments In The Next-Generation Sequencing (NGS) In Precision Medicine Market

35. Next-Generation Sequencing (NGS) In Precision Medicine Market High Potential Countries, Segments and Strategies

35.1 Next-Generation Sequencing (NGS) In Precision Medicine Market In 2029 - Countries Offering Most New Opportunities

35.2 Next-Generation Sequencing (NGS) In Precision Medicine Market In 2029 - Segments Offering Most New Opportunities

35.3 Next-Generation Sequencing (NGS) In Precision Medicine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Sequencing Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Consumables And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Library Preparation Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Bioinformatics Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Next-Generation Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Thermo Fisher Scientific Inc. Financial Performance
  • Table 81: Eurofins Scientific SE Financial Performance
  • Table 82: Agilent Technologies Inc. Financial Performance
  • Table 83: Illumina Inc. Financial Performance
  • Table 84: Bio-Rad Laboratories Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Sequencing Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Consumables And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Library Preparation Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Bioinformatics Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Next-Generation Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 81: Eurofins Scientific SE Financial Performance
  • Figure 82: Agilent Technologies Inc. Financial Performance
  • Figure 83: Illumina Inc. Financial Performance
  • Figure 84: Bio-Rad Laboratories Inc. Financial Performance

Frequently Asked Questions

Next-generation sequencing (NGS) in precision medicine refers to an advanced genomic technology that enables the rapid and comprehensive decoding of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequences at an unprecedented scale and speed, offering far deeper insights than traditional sequencing methods. It serves as a core component of precision medicine by providing a detailed view of individual genetic variation and molecular profiles, which form the basis for highly informed medical understanding and decision-making. For further insights on this market, request a sample here

The market major growth driver - Rising Incidence Of Genetic Disorders Driving The Growth Of The Market Due To Enhanced Detection And Diagnosis Capabilities. For further insights on this market, request a sample here

The next-generation sequencing (NGS) in precision medicine market size has grown rapidly in recent years. It will grow from $5.47 billion in 2024 to $6.42 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to increased government funding for genomics research, rising prevalence of genetic diseases, growth of national biobank initiatives, increased demand for targeted drugs and biomarker discovery, and emergence of multi-omics platforms. The next-generation sequencing (NGS) in precision medicine market size is expected to see rapid growth in the next few years. It will grow to $12.03 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to growing demand for personalized medicine, expanding applications beyond human genomics, rising prevalence of cancer, expansion to non-communicable disease detection, and growing awareness and accessibility of genetic testing. Major trends in the forecast period include integration with next-generation sequencing, artificial intelligence-enabled bioinformatics pipelines, integration of advanced imaging for enhanced diagnostics and treatment, advancements in sequencing chemistry, and development of cloud-based bioinformatics. For further insights on this market, request a sample here

The next-generation sequencing (NGS) in precision medicine market covered in this report is segmented as
1) By Product And Service: Sequencing Instruments, Consumables And Reagents, Library Preparation Kits, Bioinformatics Software, Next-Generation Sequencing (NGS) Services
2) By Technology: Whole Genome Sequencing (WGS), Whole Exome Sequencing (Wes), Targeted Sequencing, Ribonucleic Acid (RNA) Sequencing, Single-Cell Sequencing
3) By Application: Oncology, Infectious Disease, Rare And Inherited Disorders, Prenatal And Reproductive Health, Pharmacogenomics
4) By End Use: Hospitals And Clinics, Academic And Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations (CROs) Subsegments:
1) By Sequencing Instruments: Benchtop Sequencers, High Throughput Sequencers, Portable Sequencers
2) By Consumables And Reagents: Sequencing Reagents, Sequencing Chips, Flow Cells, Sample Preparation Reagents
3) By Library Preparation Kits: Deoxyribonucleic Acid (DNA) Library Preparation Kits, Ribonucleic Acid (RNA) Library Preparation Kits, Whole Genome Amplification Kits, Target Enrichment Kits
4) By Bioinformatics Software: Data Analysis Software, Data Management Software, Sequence Alignment Software, Variant Calling Software
5) By Next-Generation Sequencing Services: Whole Genome Sequencing Services, Whole Exome Sequencing Services, Targeted Sequencing Services, Ribonucleic Acid (RNA) Sequencing Services, Epigenomic Sequencing Services For further insights on this market,
request a sample here

North America was the largest region in the next-generation sequencing (NGS) in precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next-generation sequencing (NGS) in precision medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the next-generation sequencing (NGS) in precision medicine market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Natera Inc., Tempus Labs Inc., 10x Genomics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Fulgent Genetics Inc., Twist Bioscience Corporation, Pacific Biosciences of California Inc., Macrogen Inc., Ultima Genomics Inc., Personalis Inc., Element Biosciences Inc., Genomenon Inc., Strand Life Sciences Pvt. Ltd., and Singular Genomics Systems Inc. For further insights on this market, request a sample here.

Major trends in this market include Multimodal DNA And RNA Library Kit Advances Efficiency In Multiomic NGS For Precision Medicine For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon